NLR and PLR as novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-TNF
Citation
Düzenli, T., Köseoğlu, H., & Akyol, T. (2020). NLR and PLR as Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated with Anti-TNF. Inflammatory Bowel Diseases, 26(9), e103-e103.Abstract
To the Editors, We read with curiosity the recently published article titled “Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated with Anti-TNF: Neutrophil to Lymphocyte Ratio and Platelet-toLymphocyte Ratio” by Bertani et al.1 In the article, authors aimed to assess whether neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) could be used as prognostic markers of antitumor necrosis factor (anti-TNF) treatment response in patients with ulcerative colitis.
